Latest Financials News

Malcolm Mines NL’s subsidiary has taken key steps towards establishing a 500,000 tonnes per annum gold processing facility at Leonora, signing critical agreements for technical and funding expertise.

Kingsgate Consolidated capped a transformational 2025 with a 344% share price surge and strong cash position, setting ambitious production and exploration targets for 2026.

humm Group reports a $13.9 million statutory profit for 1H26, driven by commercial lending growth and strong consumer segment performance despite rising credit losses and regulatory costs.

Dexus Industria REIT (DXI) reported robust half-year results with 7.4% like-for-like income growth and near full occupancy, upgrading its FY26 FFO guidance. The REIT is actively recycling capital and progressing a $225 million development pipeline focused on high-quality industrial assets.

Dexus Industria REIT has slightly upgraded its FY26 funds from operations guidance, driven by robust portfolio income growth and strategic acquisitions in key industrial hubs. The REIT’s active management and development pipeline underpin its confidence in delivering secure, growing income.

Dexus Industria REIT reported a 19.3% drop in net profit for H1 FY26 but edged up its full-year FFO guidance, underpinned by strong leasing and a robust development pipeline.

Santos Limited reports a stable 2025 reserves position with a 17-year life and significant growth in CO2 storage capacity, underpinning its decarbonisation strategy. The company also provides preliminary guidance on its 2025 financial results.

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

Ionic Rare Earths is advancing its rare earth magnet recycling ambitions with strategic leadership relocation, government recognition, and new funding discussions. The company’s Belfast facility gains global significance as it targets key international markets.

Racura Oncology has developed a pioneering blood test that promises to fast-track key data on its cardioprotective drug RC220, potentially shaving two years off the clinical trial timeline. This innovation also enhances patient safety and recruitment prospects in the ongoing RAC-010 CPACS trial.

Arena REIT reported a robust half-year performance for HY2026, with net profit rising to $110 million and earnings per security up 5.4%. The company reaffirmed its FY2026 distribution guidance, underpinned by strong rental growth and disciplined capital management.

Arena REIT has reported a robust HY2026 financial performance, with net operating profit rising 9% and statutory net profit surging 202%. The REIT’s active portfolio management and development pipeline underpin its confidence in sustained growth.